Mycenax Biotech Inc. (TPEX:4726)

Mycenax Biotech Revenue

Mycenax Biotech had revenue of 121.72M TWD in the quarter ending March 31, 2025, with 51.78% growth. This brings the company's revenue in the last twelve months to 725.45M, up 22.04% year-over-year. In the year 2024, Mycenax Biotech had annual revenue of 683.92M with 4.80% growth.

• Revenue (ttm): 725.45M
• Revenue Growth: +22.04%
• P/S Ratio: 10.91
• Revenue / Employee: 1.87M
• Employees: 387
• Market Cap: 7.91B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	683.92M	31.30M	4.80%
Dec 31, 2023	652.62M	-79.66M	-10.88%
Dec 31, 2022	732.28M	-41.99M	-5.42%
Dec 31, 2021	774.27M	108.93M	16.37%
Dec 31, 2020	665.34M	274.50M	70.23%